Form 4 for TXG 10x Genomics, Inc.
Accepted 2026-05-27 17:55:41 ET · period of report 2026-05-22 · accession 0001610717-26-000162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 17:55 | 2026-05-22 | TXG | Taich Adam | CFO | S - Sale | $24.44 | -15.1K | 379.9K | -4% | -$369.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-05-22 | S | D | 15,098 | $24.44 | 379,898 | D | — | — | (F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |